LYON, France, June 24, 2025--(BUSINESS WIRE)--Regulatory News: Adocia (Euronext Paris: FR0011184241 – ADOC), a clinical-stage biopharmaceutical company focused on the research and development of ...

INDIANAPOLIS, May 29, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced that data from studies of orforglipron, insulin efsitora alfa, tirzepatide (Zepbound and Mounjaro), ...

New data from three different studies of Afrezza was announced at the American Diabetes Association’s 79th Scientific Sessions (June 7 – 11) in San Francisco. This includes safety and PK data from ...

Oral presentation on early CGM initiation receives ADA Presidents' Select Abstract of Distinction, one of eight presentations selected out of over a thousand submissions BOSTON, June 22, 2023 ...

BRIDGEWATER, N.J., May 01, 2017 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ:VLRX) today announced that multiple abstracts supporting its wearable insulin delivery technology have been ...

Skye’s CEO, CMO and CSO will be a featured panel session speakers at Evercore’s invitation-only event being held in conjunction with ADA.